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Objective: Patients with interstitial cystitis (IC) and ketamine cystitis (KC) usually have similar symp-
toms, such as frequency, urgency, and bladder pain. In patients with IC, ulcer type and nonulcer type may
have different cystoscopic features. This study investigated the clinical characteristics and bladder wall
thickness (BWT) measured using computed tomography (CT) in patients with nonulcer IC, ulcer IC, and
KC.
Materials and methods: The detailed history and bladder condition of patients with a clinical diagnosis of
IC and KC were retrospectively analyzed. An abdominal to pelvis CT scan with/without contrast was
performed in every patient. Ulcer type IC was noted in nine patients, nonulcer IC in seven patients, and
KC in 13 patients. The bladder mass volume and BWT were measured. Bladder CT images of 10 patients
with nonmetastatic renal cancer served as controls.
Results: The bladder wall was signiﬁcantly thicker in all patients with ulcer type IC (8.91 ± 2.67 mm) and
KC (10.7 ± 3.44 mm) than in those with nonulcer IC (2.89 ± 0.73 mm) or controls (2.65 ± 0.97 mm).
Among KC patients, eight patients received augmentation enterocystoplasty. Moreover, the bladder wall
was signiﬁcantly thicker in patients who underwent augmentation enterocystoplasty (11.50 ± 3.21 mm)
than those who did not (9.50 ± 3.81 mm). The bladder mass volume was increased in patients with KC
who received augmentation enterocystoplasty (35.67 ± 11.19 mL) compared with those who did not
(21.24 ± 7.25 mL). BWT signiﬁcantly correlated with visual analogue scores for pain (R2 ¼ 0.484,
p < 0.001), functional bladder capacity (R2 ¼ 0.31, p ¼ 0.002), and maximum bladder capacity
(R2 ¼ 0.469, p < 0.001) in overall patients.
Conclusion: There are obvious differences in bladder CT scans of patients with symptoms of bladder pain
due to different etiology. Increased BWT was associated with increased pain scores and decreased
bladder capacity in patients with KC and IC. BWT on a CT scan might be considered a marker for the
severity of bladder inﬂammation.
Copyright © 2015, Taiwan Urological Association. Published by Elsevier Taiwan LLC. All rights reserved.1. Introduction
Bladder pain syndrome (BPS) is a poorly deﬁned clinical con-
dition characterized by pelvic pain and urinary storage symptoms
such as urinary urgency and frequency. In a European Society for
the Study of Interstitial Cystitis proposal, BPS/interstitial cystitis
(IC) is deﬁned as “chronic pelvic pain, pressure, or discomfort
perceived to be related to the urinary bladder, with at least one
other urinary symptom such as persistent urge to void or urinaryddhist Tzu Chi General Hos-
aiwan.
ciation. Published by Elsevier Taiw
et al., Increased bladder wall
rome, Urological Science (201frequency.”1 The American Urological Association recently modi-
ﬁed the deﬁnition of IC/BPS to “an unpleasant sensation (pain,
pressure, discomfort) perceived to be related to the urinary bladder,
associated with lower urinary tract symptom(s) of more than 6
weeks' duration, in the absence of infection or other identiﬁable
causes.”2 Clinically, several bladder diseases may present with
bladder pain, including ulcer type IC, nonulcer type IC, and keta-
mine cystitis (KC).
There is no deﬁnite agreement about the pathophysiology of
and treatment algorithm for these diseases, mostly because of the
lack of objective markers and development of a clinical diagnostic
protocol.3 The clinical presentation of severe lower urinary tract
symptoms and a history of ketamine abuse usually can establish a
diagnosis of KC. A urine examination and urodynamic studies canan LLC. All rights reserved.
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stone, and bladder outlet obstruction. Cystoscopy to evaluate the
severity of cystitis using visual inspection and biopsy has played a
pivotal role in the diagnosis of KC.4 In a previous study, the most
useful imaging technique was computed tomographic (CT) urog-
raphy, which allowed assessment of both upper and lower urinary
tract dysfunction. CT ﬁndings associated with ketamine-induced
cystitis include a small bladder, diffuse bladder wall thickening,
mucosal enhancement, and inﬂammatory changes in the peri-
vesical tissue.5 In contrast to KC, few studies of CT ﬁndings in pa-
tients with IC have been reported.
Patients with a long duration of ketamine abuse might suffer
from severe bladder pain that does not respond to empirical oral or
intravesical treatment. Most of these patients have a remarkably
impaired quality of life and are at risk of developing upper urinary
tract damage including bilateral hydronephrosis and kidney
injury.6 Shahani et al7 reported CT ﬁndings in KC bladders and
found marked thickening of the bladder wall, a small capacity
bladder, and perivesical stranding consistent with severe inﬂam-
mation. In KC patients with severely contracted bladders and
intractable pain, augmentation enterocystoplasty (AE) might be
necessary to relieve refractory bladder pain and lower urinary tract
symptoms.8
Although patients with symptoms of bladder pain due to
different diseases have similar symptoms, there is no good objec-
tive diagnostic tool to evaluate the inﬂammatory status or serve as
a guide for intervention. It is mandatory to search for biomarkers in
patients with bladder pain. The aim of this study was to evaluate
the radiological features of the bladder wall on CT scans in KC and IC
patients presenting with bladder pain and to investigate the rela-
tionship between clinical characteristics and bladder wall thickness
(BWT). The results of this study may help in decision making in the
treatment of these patients.
2. Materials and methods
2.1. Patient enrollment
Patients who had symptoms of frequency, urgency, and bladder
pain and had been diagnosed as ulcer type IC, nonulcer type IC, or
KC by clinical history, physical examination, and cystoscopic
hydrodistentionwere enrolled in this study. Abdominal CT scanwas
performed after the diagnosis of bladder diseases. All patients with
these enrolled criteria were retrospectively included in this study.
All patients had been treated for >6months and had failed previous
medical treatments. Most of the patients were referred from other
hospitals for a deﬁnite treatment of their bladder pain syndrome. In
addition to the patients with KC and IC, we selected 10 patients
with nonmetastatic renal cell carcinoma ready for radical ne-
phrectomy to serve as controls.
2.2. Clinical assessment
The patients were assessed by complete history, clinical symp-
toms, urinalysis, physical examination, uroﬂowmetry, and a voiding
diary. Patients were requested to complete a 3-day voiding diary
prior to the treatment. The functional bladder capacity (FBC) was
determined by the maximal voided volume recorded in the voiding
diary or voided volume on uroﬂowmetry. The pain score was re-
ported by patient self-assessment using a 10-point visual analogue
scale (VAS) system.
Cystoscopic hydrodistention was routinely performed under
general anesthesia to search for glomerulations or bladder ulcers
(Hunner's lesion), and the maximal bladder capacity (MBC) was
determined by the bladder capacity under the intravesical pressurePlease cite this article in press as: Wu S-Y, et al., Increased bladder wall
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was deﬁned by the presence of a distinct inﬂammatory lesion with
a circumscript, reddened mucosal area with small vessels radiating
toward a central scar that ruptures with increasing bladder
distention. The ulcer might also be seen at cystoscopy without
hydrodistention.1 A bladder biopsy was performed after cysto-
scopic hydrodistention in all patients to investigate the histopa-
thology of bladder inﬂammation and determine if malignancy was
present.
2.3. Bladder CT scan and measurements
An abdominal to pelvic CT scan with or without contrast me-
dium was performed by a radiologist prior to cystoscopic hydro-
distention. During the CT scan, patients were asked to hold urine
until they felt a strong desire to void. If the patient had more than
one CT scan, only the ﬁrst CT scan prior to cystoscopic hydro-
distention was analyzed in this study.
The CT images were retrospectively reviewed by two in-
vestigators. The intravesical bladder width, height, and length were
measured from the inner border of the bladder wall at the section
with the maximal bladder size. The intravesical bladder volume
was calculated according to the following formula: intravesical
bladder height  bladder depth  bladder width  0.52. The total
bladder volumewas alsomeasured by the bladder height bladder
depth  bladder width  0.52, which were measured from the
outer border of the bladder wall. If the BWTwas equal in all parts of
the bladder wall, the maximal BWT was measured at the middle
portion of the bladder wall at the sectionwith the maximal bladder
size. If the BWT was not equally distributed (such as in ulcer type
IC), the thickest part of the bladder wall was measured as the
maximal BWT. The bladder mass volume (BMV) was measured by
subtracting the intravesical bladder volume from the total bladder
volume.
2.4. Statistical analysis
Statistical analysis was performed using one-way analysis of
variance with post hoc analysis and Pearson's regression. The VAS,
MBC, FBC, and BWT were compared among disease subgroups,
with p < 0.05 considered statistically signiﬁcant. Pearson correla-
tion coefﬁcients were calculated to determine the correlations of
VAS, FBC, and MBC with BWT. All analyses were performed using
IBM SPSS for Windows, version 12.
3. Results
The patients in the study included seven with nonulcer IC (6
women and 1 man, mean age 48.4 ± 14.4 years), nine with ulcer
type IC (all women, mean age 62.2 ± 9.71 years), and 13 KC patients.
Among the 10 control patients, eight were men and two were
women, with a mean age of 52.1 ± 17.1 years. No bladder outlet
obstruction or neurogenic bladder dysfunction was noted in these
control patients.
Among the patients with KC, eight underwent AE owing to
intractable bladder pain (4 women and 4 men, mean age
28.5 ± 5.88 years), and ﬁve did not undergo AE (1 woman and 4
men, mean age 30.0 ± 3.32 years) because their symptoms
improved after hydrodistention and they requested for conserva-
tive treatment. Table 1 lists the clinical characteristics, BWT, and
perivesical inﬁltration in these patients. Increased perivesical in-
ﬁltrations were found in ﬁve of nine patients (56%) with ulcer type
IC, in six of eight KC patients with AE (75%), and in four of ﬁve KC
patients without AE (80%), but none in patients with nonulcer IC.
Bilateral hydronephrosis was noted in three KC patients with AE.thickness is associated with severe symptoms and reduced bladder
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Table 1
The detailed bladder conditions in patients with bladder pain syndrome.
Sex Age VAS FBC (mL) MBC (mL) BMV (mL) Max. BWT (mm) Perivesical inﬁltration
IC (nonulcer)
1 F 62 4 413 850 25.6 3.7 No
2 F 42 4 250 580 8.41 2.4 No
3 F 50 3 250 600 7.91 3 No
4 F 39 5 175 820 6.98 4 No
5 F 32 3 415 700 6.85 2.4 No
6 M 41 4 413 730 13.37 2 No
7 F 73 4 227 750 19.28 2.7 No
IC (ulcer)
1 F 62 7 251 500 21.95 10 No
2 F 58 8 159 400 13.83 12 Yes
3 F 64 8 100 300 22.34 10 Yes
4 F 67 7 292 500 15.72 10.26 Yes
5 F 65 9 180 300 25.74 9.1 No
6 F 55 6 122 300 6.2 2.7 No
7 F 45 7 106 200 20.74 7.1 No
8 F 81 8 177 300 46.48 10 Yes
9 F 63 9 396 700 21.32 9 Yes
KC without AE
1 M 29 9 63 300 10.8 3 No
2 M 35 6 50 100 21.86 11 Yes
3 M 29 7 75 150 17.8 13 Yes
4 F 26 9 25 130 28.67 10.5 Yes
5 M 31 9 40 50 27.06 10 Yes
KC with AE
1 M 21 8 50 200 55.74 5 No
2 F 31 9 20 50 33.72 11 Yes
3 M 38 8 100 300 42.23 14 Yes
4 M 32 8 50 150 15.67 13 Yes
5 M 26 7 50 150 33.52 13 Yes
6 F 21 8 20 100 36.14 12 Yes
7 F 27 8 50 150 31.22 9 No
8 F 32 9 30 100 37.09 15 Yes
AE¼ augmentation enterocystoplasty; BMV¼ bladder mass volume; FBC¼ functional bladder capacity; F¼ female; IC¼ interstitial cystitis; KC¼ ketamine cystitis; M¼male;
Max. BWT ¼ maximal bladder wall thickness; MBC ¼ maximal bladder capacity; VAS ¼ visual analogue scale of pain.
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is shown in Table 2. The patients with KC were much younger than
those in the other subgroups. The VAS was signiﬁcantly higher in
both ulcer type IC and KC groups than the nonulcer IC group
(p < 0.001). Both the FBC and MBC were signiﬁcantly smaller in
patients with KC than in those with IC (p < 0.001), especially in KC
patients who received AE. In addition, patients with ulcer type IC
had signiﬁcantly smaller FBC (p ¼ 0.075) and MBC (p ¼ 0.001) than
those with nonulcer IC.
The mean BWT was 10.7 ± 3.44 mm in all KC patients,
9.5 ± 3.81 mm in the ﬁve KC patients without AE, and
11.5 ± 3.21 mm in the eight KC patients with AE. The mean BWT of
the focal thickening was 8.91 ± 2.67 mm in ulcer type IC patients.
There was no difference in BWT between the controls and nonulcer
type IC patients (p ¼ 1.00). The total BMV was signiﬁcantly greaterTable 2
Clinical data and bladder CT image parameters in patients with bladder pain syndrome.
Controls (N ¼ 10) Nonulcer IC/BPS (N ¼ 7) Ul
Age 52.09 ± 17.05 48.43 ± 14.41 6
VAS 0 3.86 ± 0.69
FBC (mL) N/A 306.4 ± 103.6 19
MBC (mL) N/A 718.6 ± 101.89 4
BWT (mm) 2.65 ± 0.97 2.89 ± 0.73
Total bladder volume (mL) 102.40 ± 57.83 93.34 ± 59.47 6
Intravesical bladder volume (mL) 80.18 ± 53.19 80.71 ± 56.01 4
Bladder mass volume (ml) 22.21 ± 6.89 12.63 ± 7.28 2
Data are presented as mean ± standard deviation.
AE ¼ augmentation enterocystoplasty; BMV ¼ bladder mass volume; CT ¼ computed tom
cystitis; Max. BWT ¼ maximal bladder wall thickness; MBC ¼ maximal bladder capacity
Please cite this article in press as: Wu S-Y, et al., Increased bladder wall
capacity in patients with bladder pain syndrome, Urological Science (201in KC patients with AE than in other groups (p < 0.001), but was not
signiﬁcantly different among the control, nonulcer IC, ulcer type IC,
and KC patients without AE. Although the BWT in ulcer type IC was
thicker than in nonulcer IC, the BMV showed no signiﬁcant differ-
ence between the two IC groups (p ¼ 0.104), indicating that the
increased maximal BWT in ulcer type IC was due to focal inﬂam-
mation at focal Hunner's lesion. The BWT in other parts of the
bladder wall was similar to that in nonulcer IC. Although an
increased BMT was also noted in KC without AE, it was likely
attributable to a smaller intravesical volume in patients of KC
without AE during CT scan.
The bladder wall in patients with nonulcer type IC was homo-
genously thin without focal thickening or perivesical inﬁltration
(Fig. 1A). The bladder wall in eight of nine patients (89%) with ulcer
type IC showed focal thickening, and the location of the focalcer type IC/BPS (N ¼ 9) KC without AE (N ¼ 5) KC with AE (N ¼ 8) p
2.22 ± 9.71 30.00 ± 3.32 28.5 ± 5.88 <0.001
7.67 ± 1.00 8.00 ± 1.41 8.13 ± 0.64 <0.001
8.11 ± 98.09 50.60 ± 19.48 46.25 ± 25.6 <0.001
28.6 ± 149.6 146.00 ± 93.97 150 ± 75.59 <0.001
8.91 ± 2.67 9.50 ± 3.81 11.50 ± 3.21 <0.001
7.02 ± 30.82 36.67 ± 10.27 58.71 ± 34.21 0.06
5.43 ± 29.68 15.43 ± 10.18 23.04 ± 26.36 0.008
1.59 ± 11.01 21.24 ± 7.25 35.67 ± 11.19 <0.001
ography; FBC ¼ functional bladder capacity; IC ¼ interstitial cystitis; KC ¼ ketamine
; VAS ¼ visual analogue scale of pain.
thickness is associated with severe symptoms and reduced bladder
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Fig. 1. Bladder computed tomography images in patients studied. (A) No speciﬁc ﬁndings in a patient with nonulcer type interstitial cystitis (IC). (B) Focal thickening in the right
lateral wall in a patient with ulcer type IC. (C) Diffused bladder wall thickening and severe perivesical inﬁltration in a patient with ketamine cystitis.
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of Hunner's lesion (Fig. 1B). The bladder wall in patients with KC
was signiﬁcantly thicker than that in the other groups, and diffuse
thickening of the bladder wall was present in every patient with KC
(Fig. 1C). Diffuse thickening of the bladder wall was found in four of
the eight KC patients with AE and two of ﬁve KC patients without
AE. Fig. 2 shows signiﬁcant correlations between the BWT and
VAS, FBC, and MBC. Patients with thicker bladder walls had higher
VAS (R2 ¼ 0.484, p < 0.001), smaller FBC (R2 ¼ 0.31, p ¼ 0.002), and
smaller MBC (R2 ¼ 0.469, p < 0.001).
4. Discussion
This study revealed that patients with ulcer type IC, nonulcer
type IC, and KC had different bladder CT ﬁndings. BWT was corre-
lated with clinical pain symptoms and reduced bladder capacity,
including FBC and MBC, in patients with KC and IC.
In previous studies, patients with IC or KC were found to have
inﬂammatory changes in the bladder wall and elevated serum in-
ﬂammatory biomarkers.9 The severity of bladder inﬂammation as
shown by increased mast cell activities has been associated with
increased urothelial apoptosis, and defective E-cadherin has been
associated with severe clinical pain symptoms.10 Signiﬁcantly more
bladder inﬂammation, urothelial apoptosis, and defective E-cad-
herin have also been reported in patients with KC than in those
with IC.11 This study further demonstrates that a thicker bladder
wall on CT scan is also associated with increased bladder pain
symptoms and reduced bladder capacity in patients who presented
with bladder pain. In ulcer type IC, focal thickening of the bladder
wall was noted, which was associated with the location of Hunner's
lesion. In KC patients, by contrast, diffused thickening of the
bladder wall was commonly seen. Perivesical inﬁltration was also
remarkable in KC patients, in both those who had and those who
did not have AE for intractable pain. These results provide evidenceFig. 2. Correlation between bladder wall thickness and visual analogue scores (VAS), fun
nonulcer interstitial cystitis, ulcer type interstitial cystitis, and ketamine cystitis.
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disease with bladder pain and might be a predictor of selecting
patients for surgical intervention such as AE in patients with KC.
The differential diagnosis of diffused bladder wall thickening on
radiology includes both neoplastic and nonneoplastic conditions.
Neoplastic conditions that may demonstrate diffuse bladder wall
thickening include transitional cell carcinoma and squamous cell
carcinoma.12 Nonneoplastic conditions causing small bladder ca-
pacity and bladder wall thickening include IC, tuberculous cystitis,
cystitis cystica, and schistosomiasis. Bladder wall thickening is also
seen following the use of chemotherapeutic agents such as cyclo-
phosphamide and radiation therapy.13 BWT has been reported to
increase in patients with bladder outlet obstruction and overactive
bladder. The detrusor is thought to increase in weight after long-
term increased workload due to bladder outlet obstruction.14
However, in one study in patients with idiopathic overactive
bladder, BWT was not different from that of controls.15
The diagnosis of IC is based on clinical symptoms, physical ex-
amination, urinalysis, and characteristic cystoscopy with hydro-
distention and biopsy.16 In 1998, it was estimated that the
prevalence of chronic pain owing to benign causes in the popula-
tion was at least 10%.17 Prevalence estimates have varied from 67/
100,000 women to 230/100,000 women18; 5e10% of the diagnosed
patients are men.19,20 In addition to bladder pain, symptoms of
urgency, frequency, and nocturia are commonly reported. Both the
European Association of Urology21 and American Urological Asso-
ciation guidelines2 indicate that BPS is a clinical diagnosis. The
European Association of Urology guidelines discuss two main
subtypes, those with and without Hunner's lesions, and their
clinical presentations and age distribution.
Studies to date strongly suggest that BPS is a syndrome with
neural, immune, and endocrine components in which activated
mast cells play a central, although not primary, pathogenetic role in
many patients.22 In our previous study, BWT measured onctional bladder capacity (FBC), and maximal bladder capacity (MBC) in patients with
thickness is associated with severe symptoms and reduced bladder
5), http://dx.doi.org/10.1016/j.urols.2015.06.154
S.-Y. Wu et al. / Urological Science xxx (2015) 1e6 5transabdominal sonography and the corrected BWT did not differ
signiﬁcantly between womenwith IC and female controls.23 In this
study, BWT was measured using CT scan and again, no difference
was found between the controls and IC patients, indicating that the
inﬂammation in IC, especially in the nonulcer type, is limited to the
urothelium and suburothelium. Five of the nine patients with ulcer
type IC had increased focal bladder wall thickening and perivesical
inﬁltration on CT scan, suggesting that bladder inﬂammation in-
volves thewhole bladder wall andmight cause severe bladder pain.
If focal thickening of the bladder wall is found in patients with ulcer
type IC, a partial cystectomy might be more effective than conser-
vative treatment.
KC was ﬁrst described by Shahani et al7 in 2007. Ketamine
dependence leads to the development of lower urinary tract
symptoms that resemble IC/BPS. According to a nationwide survey
in the United Kingdom, 26.6% of regular ketamine users reported
experiencing at least one urinary symptom.24 The symptoms were
signiﬁcantly related to both dose and frequency of ketamine use.
One histological bladder feature observed in KC is ulceration in the
presence of neutrophilic and lymphoplasma cell inﬁltration,
consistent with chronic inﬂammation.7,25 Several studies have
shown that mast cells are crucial effector cells in the immune
response implicated in the pathogenesis of IC/BPS.26 In KC, studies
have postulated that high concentrations of ketamine and its me-
tabolites in urine might have a direct toxic effect on urothelial cells,
inducing microvascular changes and neurogenic inﬂammation or
the evocation of an autoimmune response.6
Chu et al27 described reduced bladder compliance, detrusor
overactivity, and low bladder capacity in all of their patients with
KC, as well as hydronephrosis and impaired renal function in half of
them. Reduced compliance and low bladder capacity are commonly
seen in IC, except in hydronephrosis and impaired renal function. In
cystoscopy, KC patients show neovascularized areas and post-
hydrodistension hemorrhages, similar to those found in patients
diagnosed with ulcer type IC, but muchmore severe.11 In this study,
we observed bilateral hydronephrosis in three KC patients, indi-
cating that the inﬂammation had involved the lower ureters
resulting in ureteral obstruction or vesicoureteral reﬂux. This
ﬁnding is also compatible with severe perivesical inﬂammatory
changes in patients with KC. The presence of a thickened bladder
wall, reduced bladder capacity, perivesical inﬁltration, and hydro-
nephrosis indicate the necessity for early surgical intervention to
provide rapid relief of intractable pain and an early return to society
for KC patients.15
Patients with KC or IC have severe lower urinary tract symptoms
and bladder pain. Urodynamic study and cystoscopy without
anesthesia usually cause severe pain and intolerance to completion
of the studies. Therefore, these studies cannot demonstrate the
extent of the disease and are inconclusive in evaluating these pa-
tients. By contrast, bladder CT scan can provide clear images of both
the lower and upper urinary tract for evaluation. CT has been
considered themost useful imaging tool in evaluating patients with
KC, and demonstrates a small bladder, diffuse bladder wall thick-
ening, mucosal enhancement, and inﬂammatory changes in the
perivesical fat.5 Measuring BWT on CT scan can not only identify a
pancystitis such as in KC, but can also provide evidence for early
surgical intervention.
The results of this study showed different ﬁndings in bladder CT
scans in patients presenting bladder pain from different diseases.
Because an increased BWT is associated with a higher VAS, reduced
FBC, and smaller MBC, the results suggest that bladder CT is a useful
investigative tool for evaluation of the severity of bladder inﬂam-
mation in patients with bladder pain. BWT might be used as a
predicting factor for early, unavoidable surgical intervention in
these patients.Please cite this article in press as: Wu S-Y, et al., Increased bladder wall
capacity in patients with bladder pain syndrome, Urological Science (201Although BWT was increased in patients with ulcer type IC and
KC, factors that might induce thickening of the bladder wall should
be searched for, such as aging, bladder outlet obstruction, and
neurogenic bladder dysfunction. In this study, most of the patients
with KC were young and most of the patients with IC/BPS were
women. Neurogenic bladder dysfunction and bladder outlet
obstruction can be ruled out by videourodynamic study in the
diagnostic procedures. Nevertheless, the confounding factors of
increased BWT should be considered.
The main limitations of the present study were the small case
number and the difﬁculty in measuring the exact maximal bladder
volume during CT scan. Furthermore, the CT scan was performed
every 2.5 cm as one cut, which may have caused test errors in
measuring the exact bladder volume. Nevertheless, the diffuse
bladder wall thickening in KC bladders, focal bladder wall thick-
ening in ulcer type IC bladders, and increased perivesical inﬁltra-
tion in most KC bladders were are not affected by these potential
technical errors.
5. Conclusion
There are obvious differences in bladder CT scans of patients
with nonulcer IC, ulcer type IC, and KC. Bladder CT is useful for the
evaluation of the severity of bladder inﬂammation and differential
diagnosis in patients with KC and IC. BWTmight also be a predictor
of identifying patients for surgical intervention such as AE in pa-
tients with KC.
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